New Probiotic Medical Food Receives Approval for Use in Singapore
A new medical food product called Neuralli™ MP has officially entered the Singapore market. The product recently met the notification requirements set by the Health Sciences Authority (HSA), allowing it to be sold to consumers in the country.
Neuralli™ MP contains a unique ingredient known as PS128™. This is a type of "psychobiotic," which is a probiotic supplement specifically designed to support mental well-being. According to the manufacturer, this ingredient works by helping to balance important chemicals in the body, such as serotonin and dopamine.
These two chemicals, often referred to as "happy hormones," play a significant role in regulating mood and emotional health. By targeting these areas, the product aims to provide a new option for individuals looking to support their neurological health through nutrition.
This development marks a global expansion for the brand, which is already available in the United States. With the HSA notification now complete, Singaporean consumers can access this product as part of their health and wellness routines.
As with any new medical food or health supplement, experts generally recommend that individuals consult with a doctor or healthcare professional before starting a new product. This ensures that the supplement is suitable for their specific health needs.